SCHEMBL13339752

SCHEMBL13339752

O=C1CC2(CCNCC2)Oc2cccnc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 6/20 0.49
EPHX2 P34913 1/20 0.49
OPRD1 P41143 1/20 0.41
HDAC3 O15379 4/20 0.40
HDAC4 P56524 4/20 0.40
HDAC1 Q13547 4/20 0.40
HDAC7 Q8WUI4 4/20 0.40
HDAC2 Q92769 4/20 0.40
HDAC10 Q969S8 4/20 0.40
HDAC11 Q96DB2 4/20 0.40
HDAC8 Q9BY41 4/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC9 Q9UKV0 4/20 0.40
HDAC5 Q9UQL6 4/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
ATM Q13315 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3493117 0.99 ACACB (0.48) ACACBEPHX2OPRD1HDAC3HDAC4
SCHEMBL15469500 0.87 EPHX2 (0.52) ACACBEPHX2ADRA1DADRA1AADRA1B
SCHEMBL21617954 0.85 ACACB (0.46) ACACBEPHX2HDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL23928889 0.84 ACACB (0.45) ACACBEPHX2HDAC3HDAC4HDAC1
SCHEMBL1115206 0.84 EPHX2 (0.50) ACACBEPHX2ADRA1DADRA1AADRA1B
Hydrochloric Acid SCHEMBL30587434 0.84 ACACB (0.45) ACACBEPHX2HDAC3HDAC4HDAC1
SCHEMBL12410064 0.80 OPRD1 (0.39) ACACBEPHX2OPRD1
SCHEMBL31282729 0.79 OPRD1 (0.41) ACACBEPHX2OPRD1HDAC3HDAC4
SCHEMBL24879269 0.79 OPRD1 (0.41) ACACBEPHX2OPRD1HDAC3HDAC4
SCHEMBL14919198 0.79 EPHX2 (0.64) ACACBEPHX2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113418-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-06 US disclosed
US-20100113418-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-06 US disclosed
EP-2123652-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113418-A1 HETEROCYCLIC COMPOUND ACACA, ACAT1, CPT1B ACACB 5/4885EPHX2 2750/4885OPRD1 4498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.